Standex (SXI) director granted 639 restricted shares, 3-yr vest
Standex International (SXI) director reported an equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Standex International (SXI) director reported an equity grant. On 10/21/2025, the reporting person acquired 639 shares of common stock as a grant of restricted stock under the Company’s 2018 Omnibus Incentive Plan, vesting three years after the grant date. The filing lists the transaction price as $0, consistent with a stock grant. Following the grant, the filer beneficially owned 3,575 shares directly and 13,751 shares indirectly as trustee of a trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 639 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Standex (SXI) disclose in this Form 4?
What are the vesting terms of the SXI restricted stock grant?
What is the filer’s relationship to Standex (SXI)?
AI-generated analysis. How Rhea-AI works. Not financial advice.